Chemical Compound

c-di-GMP

CAS Registry Number 61093-23-0
c-di-GMP chemical structure
Primary Record

c-di-GMP

Note: Only for scientific research or as raw materials for production.

In stock
6,673 g
Purity
99.3 %
CAS
61093-23-0

Compound Identifiers & Properties

CAS
61093-23-0
PubChem CID
135440063
SMILES
C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)OP(=O)(OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C6N=C(NC7=O)N)O)OP(=O)(O1)O)O
Canonical SMILES
Nc1nc2c(ncn2[C@@H]2O[C@@H]3COP(=O)(O)O[C@H]4[C@@H](O)[C@H](n5cnc6c(=O)[nH]c(N)nc65)O[C@@H]4COP(=O)(O)O[C@H]3[C@H]2O)c(=O)[nH]1

Names & Synonyms

  • c-di-GMP
  • Cyclic-di-GMP
  • cyclic di-GMP
  • cGpGp
  • cdiGMP
  • Cyclic diguanylate
  • Cyclicdiguanylate
  • c-diGMP
  • Cyclic diguanylic acid
  • 61093-23-0
  • c-(Gpgp)
  • 3',5'-Cyclic diguanylic acid
  • 3',5'-Cyclic diGMP
  • cyclic di-3',5'-guanylate
  • 5GP-5GP
  • Bis-(3',5')-cyclic diGMP
  • RefChem:1080542
  • Bis(3',5')-cyclic diguanylic acid
  • CHEMBL1231573
  • CHEBI:49537
  • orb533279
  • dyclic diguanylate monophosphate
  • PKFDLKSEZWEFGL-MHARETSRSA-N
  • Cyclic diguanosine monophosphate
  • DTXSID801027528
  • orb1709965
  • orb1733740
  • Cyclic di-3/',5/'-guanylate
  • SCHEMBL17974376
  • GTPL13137
  • DTXCID701511702
  • 61093-23-0 (free acid)
  • Cyclic-bis(3',5')diguanylic acid
  • EX-A6951
  • C20H24N10O14P2
  • BDBM50436163
  • ZINC72319544
  • 3 ,5 -Cyclic diguanylic acid
  • AKOS040732890
  • Cyclic bis (3',5') diguanylic acid
  • CID6323195
  • CS-7977
  • NC46014
  • BP-58810
  • DA-52212
  • c-di-GMP; Cyclic diguanosine monophosphate
  • C20-H24-N10-O14-P2
  • HY-107780
  • J687.951I
  • Bis-(3'-5')-cyclic dimeric guanosine monophosphate
  • C16463
  • 9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10,12-Tetrahydroxy-5,12-Dioxidooctahydro-2h,7h-Difuro[3,2-D:3',2'-J][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-Diyl]bis(2-Amino-1,9-Dihydro-6h-Purin-6-One)
  • Q2649761
  • 2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
  • B2001-006107
  • 3'-Guanylic acid, guanylyl-(3'-->5')-, cyclic nucleotide
  • (1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-hydroxypurin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecane-9,18-diol
  • 3 -O,5 -O-[(Guanosine-3 -O,5 -O-diyl)bisphosphinico]guanosine
  • 3 -O,5 -O-[(Guanosine-5 -O,3 -O-diyl)bisphosphinico]guanosine
  • 3 -O,5 -O-[Guanosine-5 -O,3 -O-diylbis(phosphinico)]guanosine
  • 3 -O,5 -O-Phosphinico-3 -O,5 -O-phosphinicobisguanosine
  • Cyclic diguanosine monophosphate(c-digmp/c-di-gmp)/ cyclic bis diguanylic acid
  • Guanosine 3 ,5 -bisphosphoric acid 3 ,5 -dideoxyguanosine-5 ,3 -diyl ester
  • (1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3,12-diphosphatricyclo[13.3.0.0,octadecane-3,12-dione
  • (1S,6R,8R,9R,10S,15R,17R,18R)-8,17-bis(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.3.0.06,10]octadecane-3,12-dione
  • 2-amino-9-((1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo(13.3.0.06,10)octadecan-8-yl)-1H-purin-6-one
  • 2-amino-9-[(1S,6R,8R,9R,10S,15R,17R,18R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3|E5,12|E5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
  • 9,9'-((2R,3R,3aS,7aR,9R,10R,10aS,14aR)-3,5,10,12-Tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9]tetraoxa[2,8]diphosphacyclododecine-2,9-diyl)bis(2-amino-3,9-dihydro-6H-purin-6-one)
  • C2E